Screening for an inherited susceptibility to colorectal cancer

被引:10
|
作者
Rowley, PT
机构
[1] Univ Rochester, Sch Med, Div Genet, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Med, Rochester, NY 14642 USA
来源
GENETIC TESTING | 2004年 / 8卷 / 04期
关键词
D O I
10.1089/gte.2004.8.421
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The principal Mendelian disorders predisposing to colorectal cancer are familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC). FAP is caused by mutations in the adenomatous polyposis coli (APC) gene. HNPCC is caused by a mutation in one of at least five mismatch repair genes. It is important to identify individuals with these conditions because colon cancer will occur in at least 80% and onset is earlier than in the general population. Potential benefits of identification include improved compliance with recommended surveillance, early detection of polyps, reduction in cancer mortality, and reassurance for relatives found to be negative with attendant savings in the time and expense of surveillance. For classic FAP, the large number of polyps readily identifies affected persons. For HNPCC, identification of individuals meriting DNA sequencing requires either recognition of a suspect family history or finding high microsatellite instability in a tumor. Individuals accepting the offer of genetic counseling and DNA testing often have more cancers in their family, are motivated to inform relatives, have a larger social network, and have more confidence in their coping ability. Individuals who decline are often concerned about their own or their family's emotional reaction or fear discrimination.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [21] Pharmacotherapy for inherited colorectal cancer
    Lynch, Patrick M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1101 - 1108
  • [22] Colorectal polyposis and inherited colorectal cancer syndromes
    Byrne, Raphael M.
    Tsikitis, Vassiliki Liana
    ANNALS OF GASTROENTEROLOGY, 2018, 31 (01): : 24 - 34
  • [23] Testing for Inherited Susceptibility to Breast Cancer
    Robson, Mark
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 17 - 31
  • [24] Mismatch repair and inherited cancer susceptibility
    Kolodner, R
    FASEB JOURNAL, 1997, 11 (09): : A1301 - A1301
  • [25] Inherited susceptibility to breast and ovarian cancer
    Diamond, TM
    Sutphen, R
    Tabano, M
    Fiorica, J
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1998, 10 (01) : 3 - 8
  • [26] INHERITED CANCER SUSCEPTIBILITY IN AN ELDERLY ADULT
    Mariano, Caroline
    Jolly, Trevor
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 (07) : 1406 - 1408
  • [27] Examining the Role of Perceived Susceptibility on Colorectal Cancer Screening Intention and Behavior
    McQueen, Amy
    Vernon, Sally W.
    Rothman, Alexander J.
    Norman, Gregory J.
    Myers, Ronald E.
    Tilley, Barbara C.
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 40 (02) : 205 - 217
  • [28] Screening for susceptibility genes in hereditary non-polyposis colorectal cancer
    Yu, Li
    Yin, Bo
    Qu, Kaiying
    Li, Jingjing
    Jin, Qiao
    Liu, Ling
    Liu, Chunlan
    Zhu, Yuxing
    Wang, Qi
    Peng, Xiaowei
    Zhou, Jianda
    Cao, Peiguo
    Cao, Ke
    ONCOLOGY LETTERS, 2018, 15 (06) : 9413 - 9419
  • [29] SCREENING FOR SUSCEPTIBILITY TO COLORECTAL-CANCER - TECHNOLOGY AHEAD OF ITS TIME
    KEE, F
    COLLINS, BJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1991, 3 (03) : 195 - 199
  • [30] A review of inherited cancer susceptibility syndromes
    Brown, Gina R.
    Simon, Madeline
    Wentling, Chris
    Spencer, Danielle M.
    Parker, Ashley N.
    Rogers, Corey A.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2020, 33 (12): : 10 - 16